Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The impact of CAR density on the antitumoral efficacy of BCMA CAR-T cells in multiple myeloma

In this video, Felipe Prosper, MD, PhD, University of Navarra, Pamplona, Spain, reports on a study that evaluated the impact of CAR density on the efficacy of anti-BCMA CAR-T cells in patients with multiple myeloma. Patients treated with CAR-T cell products with low CAR expression had significantly better clinical responses. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.